RNA-Modulating Small Molecule Drugs Icon

Cambridge Healthtech Institute’s 5th Annual

RNA-Modulating Small Molecule Drugs

Novel Approaches to Target RNA Structure, Binding, Interactions, and Function

APRIL 3 - 4, 2024


With an increased understanding of diverse RNA moieties, their structure, function, and interactions, finding small molecules to target RNA is getting simpler. Small molecules offer enhanced stability, oral bioavailability, and better drug-like properties when compared to oligonucleotides. Hence, they are a more viable therapeutic option. However, identifying the right disease-causing RNA and evaluating the downstream physiological responses after small molecule modulation can be quite challenging. Challenges also exist in terms of optimizing the specificity, selectivity, and safety of these small molecules in vivo. Cambridge Healthtech Institute’s conference on RNA-Modulating Small Molecule Drugs will highlight some of the innovative approaches and technologies being used in this field.

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute

Email: tkoppal@healthtech.com


For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com